Raise Funds for World-Class Breast Cancer Research
Breast cancer is still the most diagnosed cancer in Australia. Ageing population, health and lifestyle factors and better detection have all contributed to an increase in breast cancer diagnoses rates.
In 2021, 55 Australians will be diagnosed with breast cancer every day in Australia.
To improve breast cancer survival rates for those living with breast cancer, research is key. With your support we can continue to fund novel and scientific research into new and improved treatments to ensure those living with breast can have the best possible outcome.
To reach our goal of Zero Deaths from breast cancer by 2030, we need your help.
You'll be helping us stop deaths from breast cancer
As a 100% community funded organisation, we rely entirely on the generosity of our community and individuals like you who believe in the power of research.
Australians are diagnosed with breast cancer every day in Australia
Women will be diagnosed with breast cancer in their lifetime
Men will be diagnosed in their lifetime
Meet two NBCF funded researchers
Dr Roberta Mazzieri
University of Queensland
Vaccinations for Triple Negative and Brain Metastatic Breast Cancer
Triple negative breast cancer and brain-metastatic breast cancer remain the two most challenging subtypes of breast cancer to treat due to their poor responsiveness to common chemotherapy treatments such as hormone therapy and HER2-targeting drugs. As such, new options are urgently needed for women with these two subtypes of breast cancer.
Dr Mazzieri’s project hopes to address this with a new vaccination-based technology which stimulates immune cells to better recognise and eliminate cancer cells. Ultimately, this method will help boost the patients response to immunotherapy in breast cancer
Professor Jane Visvader
Walter and Eliza Hall Institute of Medical Research
Unravelling Breast Cancer Complexity
Aggressive breast cancer subtypes such as triple-negative breast cancer and BRCA-2 associated cancers are challenging to treat due to the numerous different cells within the tumour. This cell variation makes the cancer difficult to predict in terms of it’s responsiveness to drug therapies. Using an advanced suite of new technologies, Professor Visvader’s work will study thousands of single cells to determine how individual cells behave, and how this influences the spread of cancer in the body.
About the National Breast Cancer Foundation
The National Breast Cancer Foundation is Australia’s leading national body funding game-changing breast cancer research. Our mission is simple: stop deaths from breast cancer. How? By identifying, funding and championing world-class research – research that will help us detect tumours earlier, improve treatment outcomes, and ultimately – save lives.
More than ever, NBCF is focussing keenly on how we can do more with less in order to achieve great outcomes that will impact the longevity and quality of life for patients with breast cancer.
For us, this means identifying new and effective models of funding and ensuring that we don’t stand alone but work collaboratively and creatively to achieve our mission of Zero Deaths from breast cancer by 2030.